Ticker: VTGN

Company Overview Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company focused on developing non-systemic intranasal treatment options targeting CNS disorders via their proprietary pherine technology. The company's pipeline includes multiple product candida...

Company Overview:Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company focused on developing novel intranasal therapies targeting neuropsychiatric disorders. Recent Financial Performance: Net Loss: Net loss for Q3 2024 was $14.1 million, an increase from $6.4 m...